Cipla Q4 Results: Profit Falls 33%, Margin Contracts
Vaccine vials enter the conveyor of a machine during inspection and screening for defects. (Photographer: Sanjit Das/Bloomberg)

Cipla Q4 Results: Profit Falls 33%, Margin Contracts

Drugmaker Cipla Ltd.’s profit declined in the March quarter on account of a high base and relatively lower sales amid the coronavirus lockdown.Net profit fell 33 percent over the previous year to R...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.